and clinicians among the various roles and aspects of the bladder tumor microenvironment and its responses to immune modulation, to further our knowledge in this field. The immune micro-environment of ...

Comprehensive bladder cancer molecular profiling and monitoring based on mutational, epigenomic, and expression data from real-world patients. This is an ASCO Meeting Abstract from the 2025 ASCO ...

The Impact of the COVID-19 Pandemic on Urologic Cancer Care ...

The term nonmuscle invasive bladder cancer covers a spectrum of tumors with varying degrees of clinical behavior. The low-grade Ta lesions commonly recur but rarely progress to muscle invasion.

At further upstream, the inflammation-related NFKB transcription factor inhibits miR-29b/c expression, driving UPR-related tumor progression and determining poor survival in bladder cancer patients.

but its clinical use is restricted due to limited sensitivity in detecting low-grade tumors and high false negatives. In the study, "Urinary DNA Methylation Test for Bladder Cancer Diagnosis ...

Genome-scale metabolic reconstruction of urinary microbiome: Pathway for personalized medicine. Frequency and impact of a genome-wide homologous recombination deficiency signature (HRDsig+) on the ...

Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation ... involves transurethral resection of the tumor, followed by chemotherapy and radiation.

Urothelial cancer ... both bladder cancers and UTUCs can present with hematuria (blood in the urine). However, UTUCs can block the ureter or kidney, causing swelling (known as hydronephrosis) and ...